CASE STUDY
Eliminated redundant systems, saving nearly $5M annually
Shortened cross-departmental workflows
Unified tools across R&D, QA, and Compliance
Secure and validated transactions across all labs
A global pharma manufacturer struggled with a patchwork of legacy systems across its R&D, regulatory, and manufacturing arms. Disconnected platforms led to duplicated data, manual re-entry, and compliance blind spots—resulting in costly delays and operational inefficiencies. Digital initiatives launched in isolation failed to scale, burdening teams with more tools but fewer insights. Leadership recognized that without a cohesive ecosystem, speed-to-discovery and regulatory agility would remain constrained.
We delivered an end-to-end ecosystem transformation—starting with a full systems audit to surface redundancies and fragmentation. Our team then designed a cloud-native architecture that integrated LIMS, ERP, and quality systems into a unified, intelligent platform. AI agents simulated workflows and flagged integration friction points, enabling phased consolidation without disruption. Through collaborative planning and change enablement, we ensured adoption at every level—turning fragmented tools into a strategic asset for innovation, compliance, and scale.
When legacy systems stalled the line, we rebuilt the digital chassis—connecting design, production, and logistics to fuel faster turns at global scale
Where fragmented systems stalled care, we rebuilt healthcare’s digital backbone—unifying data, speeding access, and powering seamless experiences at scale.
In PE, where timing is alpha, we built a digital engine that tracks deals, flags risk, and syncs teams—turning slow diligence into competitive velocity.